Tissue Banking Market Research Report Forecast till 2030
Market Overview
Tissue Banking Market is anticipated to register a healthy CAGR of 8.5% during the review period.
The rising predominance of constant sicknesses like malignant growth, coronary illness, and diabetes infection significantly influence all around the world as well as raises the interest for cutting edge treatment options for the treatment of persistent sickness. As rising gamble of constant sickness appears to be the best treatment elective for tissue banking. What's more, according to the American Malignant growth Society, around 1.9 million new instances of disease were analysed in the US. Moreover, coronary illness is considered as the main source of death for ladies and men. One individual kick the bucket like clockwork in the US from cardiovascular illness. Around 4,66,566 individuals experienced coronary illness in the US. Coronary illness costs the US around USD 239.9 billion consistently from 2018 to 2019. Hence, the rising commonness of coronary illness disease, and diabetes is expanding the interest in tissue banking so central participants are distinctly interested in the research and improvement movement for new item advancement which pushes the development of tissue banking.
Market Segmentation
The Tissue Banking Market segmentation, based on type, includes media and consumable, cryopreservation equipment, thawing equipment, quality control equipment, and others.
The Tissue Banking Market segmentation is based on tissue types that include heart valve, cornea, bone, skin, brain & spinal cord, and others.
The Tissue Banking Market segmentation is based on applications that include therapeutics, medical research, and others.
Regional Insights
North America represented the biggest market share in 2022 attributable to the North Americas is supposed to order the biggest market share because of the rising propensity of egg frozen in the US, accessibility of advance innovation, expanding medical care framework, created monetary condition boos the development of tissue banking in the North America region.
Europe tissue banking market is supposed to represent the second-biggest market share because of the development of the market are expanding mechanical turn of events and item advancement, rising research and improvement movement, expanding event of life threating sickness like coronary illness, malignant growth, and others. Moreover, expanding quantities of organ contributors across the region is driving the development of tissue banking.
The Asia-Pacific tissue banking market is anticipated to register a CAGR of 6.90% during the review period. This is because of expanding venture by unfamiliar organizations, colossal ongoing sickness populace, expanding entrance of frozen eggs are driving the development of tissue banking in the Asia-pacific region.
Latin America holds the significant market share in the middle east and Africa region because of the region's development is credited to a developing utilization of tissue banking, rising mindfulness about the organ gift for saving other life, developing new mechanical turn of events and advance clinical office across the region are help the development of tissue banking in region.
Major Players
The key market players are Applied Biosystems, Custom Biogenic Systems (US), Invitrogen, Thermo Scientific, Fisher Scientific, Cesca Therapeutics, Inc. (US), Unity Lab Services, BioLife Solutions (US), Atlanta Biologics Pvt. Ltd. (US), Lifeline Scientific (US), BioCision, core dynamics GmbH (US), Taylor-Wharton (US), and Panasonic Holdings Corporation (Japan).
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 GLOBAL TISSUE BANKING MARKET, SYNOPSIS, 2019–2030
TABLE 2 GLOBAL TISSUE BANKING MARKET, ESTIMATES & FORECAST, 2019–2030 (USD BILLION)
TABLE 3 GLOBAL TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 4 GLOBAL TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 5 GLOBAL TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 6 NORTH AMERICA: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 7 NORTH AMERICA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 8 NORTH AMERICA: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 9 US: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 10 US: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 11 US: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 12 CANADA: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 13 CANADA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 14 CANADA: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 15 EUROPE: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 16 EUROPE: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 17 EUROPE: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 18 GERMANY: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 19 GERMANY: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 20 GERMANY: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 21 FRANCE: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 22 FRANCE: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 23 FRANCE: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 24 ITALY: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 25 ITALY: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 26 ITALY: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 27 SPAIN: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 28 SPAIN: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 29 SPAIN: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 30 UK: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 31 UK: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 32 UK: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 33 REST OF EUROPE: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 34 REST OF EUROPE: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 35 REST OF EUROPE: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 36 ASIA-PACIFIC: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 37 ASIA-PACIFIC: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 38 ASIA-PACIFIC: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 39 JAPAN: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 40 JAPAN: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 41 JAPAN: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 42 CHINA: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 43 CHINA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 44 CHINA: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 45 INDIA: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 46 INDIA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 47 INDIA: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 48 AUSTRALIA: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 49 AUSTRALIA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 50 AUSTRALIA: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 51 SOUTH KOREA: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 52 SOUTH KOREA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 53 SOUTH KOREA: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 57 REST OF THE WORLD: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 58 REST OF THE WORLD: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 59 REST OF THE WORLD: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 60 MIDDLE EAST: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 61 MIDDLE EAST: TISSUE BANKING MARKET, BY THERAPY, 2019–2030 (USD BILLION)
TABLE 62 MIDDLE EAST: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 63 AFRICA: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 64 AFRICA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 65 AFRICA: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
TABLE 66 LATIN AMERICA: TISSUE BANKING MARKET, BY TYPE, 2019–2030 (USD BILLION)
TABLE 67 LATIN AMERICA: TISSUE BANKING MARKET, BY TISSUE TYPE, 2019–2030 (USD BILLION)
TABLE 68 LATIN AMERICA: TISSUE BANKING MARKET, BY APPLICATION, 2019–2030 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL TISSUE BANKING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL TISSUE BANKING MARKET
FIGURE 4 GLOBAL TISSUE BANKING MARKET, SHARE (%), BY TYPE , 2022
FIGURE 5 GLOBAL TISSUE BANKING MARKET, SHARE (%), BY TISSUE TYPE, 2022
FIGURE 6 GLOBAL TISSUE BANKING MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 7 GLOBAL TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: TISSUE BANKING MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL TISSUE BANKING MARKET: COMPANY SHARE ANALYSIS (%), 2022
FIGURE 13 THERMO FISHER SCIENTIFIC INC : FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 THERMO FISHER SCIENTIFIC INC : SWOT ANALYSIS
FIGURE 15 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 ASTRAZENECA: SWOT ANALYSIS
FIGURE 17 BIOLIFESOLUTIONS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 BIOLIFESOLUTIONS: SWOT ANALYSIS
FIGURE 19 LIFELINE SCIENTIFIC : FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 LIFELINE SCIENTIFIC : SWOT ANALYSIS
FIGURE 21 BIOCISION, CESCA THERAPEUTICS, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 BIOCISION, CESCA THERAPEUTICS, INC: SWOT ANALYSIS
FIGURE 23 CORE DYNAMICS GMBH : FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 CORE DYNAMICS GMBH : SWOT ANALYSIS
FIGURE 25 CUSTOM BIOGENIC SYSTEMS : FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 CUSTOM BIOGENIC SYSTEMS : SWOT ANALYSIS
FIGURE 27 ATLANTA BIOLOGICS PVT. LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 ATLANTA BIOLOGICS PVT. LTD: SWOT ANALYSIS
FIGURE 29 TAYLOR-WHARTON : FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 TAYLOR-WHARTON : SWOT ANALYSIS
FIGURE 31 PANASONIC HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 PANASONIC HOLDINGS CORPORATION: SWOT ANALYSIS
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們